Skip to main content
. 2011 Jun 7;35(1):9–18. doi: 10.1007/s13402-011-0052-6

Table 1.

Patient characteristics

All tumors (n = 361)
Age (mean, min-max, SD) 57.5 16–89 SD 13.2
Age; grouped n %
<58 years old 168 46.5
≥58 years old 192 53.2
Missing 1 0.3
Tumor type n %
Serous adenocarcinoma 210 64.4
Other 116 35.6
- Mucinous adenocarcinoma 40 12.3
- Endometrioid adenocarcinoma 51 15.6
- Clear cell carcinoma 22 6.8
- Undifferentiated 3 0.9
Missing 35
FIGO-stage n %
Stage I 70 19.4
Stage II 30 8.3
Stage III 205 56.8
Stage IV 54 15.0
Missing 2 0.6
Grade n %
Grade I 57 15.8
Grade II 96 26.6
Grade III 160 44.3
Undifferentiated 15 4.2
Missing 33 9.1
Rest tumor after primary surgery n %
Yes 224 62.0
No 125 34.6
Missing 12 3.3
Size of rest tumor n %
<2 cm 168 46.5
≥2 cm 163 45.2
Missing 30 8.3
Progression free survival (months)
(mean, min-max, SD) 29.6 0–207 SD 36.3